# Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis

> **NCT02941419** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Jordan** · enrollment: 10 (actual)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **BIOLOGICAL:** Platelet lysate

## Key facts

- **NCT ID:** NCT02941419
- **Lead sponsor:** University of Jordan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-05
- **Primary completion:** 2016-09-15
- **Final completion:** 2017-02-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02941419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02941419, "Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02941419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*